Jamie W. Robinson

机构：Boehringer Ingelheim (Germany), University of Bristol · ORCID：0000-0001-8721-6514

发表论文 48 篇 · 总被引 1753 次 · h-index 14

代表论文

• Genetic regulation of the human plasma proteome in 54,306 UK Biobank participants (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 130)
• Evaluating the efficacy and mechanism of metformin targets on reducing Alzheimer’s disease risk in the general population: a Mendelian randomisation study (2022 · Diabetologia · 被引 113)
• Association between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis (2024 · EBioMedicine · 被引 50)
• Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome‐Wide Association Meta‐Analysis Followed by Mendelian Randomization (2023 · Arthritis & Rheumatology · 被引 42)
• An efficient and robust tool for colocalisation: Pair-wise Conditional and Colocalisation (PWCoCo) (2022 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 35)
• The effect of SGLT2 inhibition on prostate cancer: Mendelian randomization and observational analysis using electronic healthcare and cohort data (2024 · Cell Reports Medicine · 被引 24)